Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

New Study Highlights Cancer Risk Linked to Tamoxifen

Filed July 5th, 2013 Joshua Sophy

New research is revealing why the breast cancer drug tamoxifen may actually increase a woman’s chance of developing another type of cancer over other drugs used to treat breast cancer.

According to a report from NewsFix.ca on a study from the Dana-Faber Cancer Institute, tamoxifen is responsible for promoting the growth of cells that can cause uterine cancer even if it has proven to be an effective treatment in the prevention of breast cancer. The study shows that tamoxifen blocks the flow of estrogen to the breast which, in turn, attempts to block cancer development. However, “secondary molecules are ‘recruited’ to a site on the cell when tamoxifen binds to it,” according to the report. This promotes cancer cell growth in the uterus. These molecules actually promote cancer cell growth.

This side effect was not noticed in a comparison study of another breast cancer drug, raloxifene. The study, it was noted in the NewsFix.ca report, should help drug developers create new cancer drugs that do not promote other cancer cell growth despite preventing one type of cancer. Tamoxifen is in a class of drugs known as Selective Estrogen Receptor Modulators (SERMs).

Based on our previous reporting, uterine cancer is not the only drawback to taking tamoxifen. Women who’ve taken tamoxifen in the past in the hope of treating or preventing breast cancer have suffered serious side effects such as stroke, blood clots in their lungs, and endometrial cancer.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!